Annual report pursuant to Section 13 and 15(d)

Summary of Significant Accounting Policies (Restated) - Summary of impact of the restatement (Details)

v3.22.2.2
Summary of Significant Accounting Policies (Restated) - Summary of impact of the restatement (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 12 Months Ended
Dec. 31, 2021
Sep. 30, 2021
Dec. 31, 2021
Dec. 31, 2020
Sep. 30, 2022
Dec. 31, 2019
Consolidated Balance Sheet:            
Contingent earnout liability $ 10,026   $ 10,026 $ 0    
Total liabilities 99,987   99,987 93,158    
Additional paid-in capital 438,696   438,696 10,131    
Accumulated deficit (249,236)   (249,236) (211,146)    
Total stockholders' equity (deficit) 190,207   190,207 (48,736)   $ (18,655)
Total liabilities and stockholders’ equity (deficit) 290,194   290,194 44,422    
Consolidated Statements of Operations:            
Change in fair value of contingent earnout liability     48,248 0    
Total other income (expense), net     30,233 (6,093)    
Loss before income taxes     (37,593) (32,104)    
Net loss     $ (38,090) $ (32,504)    
Basic net income (loss) per share     $ (0.61) $ (1.85)    
Diluted net income (loss) per share     $ (0.61) $ (1.85)    
Consolidated Statements of Comprehensive Loss:            
Net loss     $ (38,090) $ (32,504)    
Comprehensive loss     (36,376) (32,858)    
Consolidated Statements of Changes in Stockholders' Equity (Deficit):            
Contingent Earnout Liability Upon Closing Of The Merger     (58,274)      
Additional paid-in capital 438,696   438,696 10,131    
Accumulated deficit (249,236)   (249,236) (211,146)    
Total stockholders' equity (deficit) 190,207   190,207 (48,736)   $ (18,655)
Net Income (Loss) Attributable to Parent     (38,090) (32,504)    
Ending balance 190,207   190,207 (48,736)    
Consolidated Statements of Cash Flows:            
Net loss     (38,090) (32,504)    
Change in fair value of contingent earnout liability     (48,248)      
Net Cash used in operating activities     (57,986) $ (14,773)    
Noncash Investing and Financing Items [Abstract]            
Contingent earnout liability recognized upon the closing of the reverse recapitalization     58,274      
As Previously Reported            
Consolidated Balance Sheet:            
Contingent earnout liability 11,369 $ 77,131 11,369      
Total liabilities 101,330 200,274 101,330      
Additional paid-in capital 418,575 393,872 418,575      
Accumulated deficit (230,458) (290,407) (230,458)      
Total stockholders' equity (deficit) 188,864 103,289 188,864      
Total liabilities and stockholders’ equity (deficit) 290,194   290,194      
Consolidated Statements of Operations:            
Change in fair value of contingent earnout liability     67,026      
Total other income (expense), net 83,511 (15,060) 49,011      
Loss before income taxes 59,477 (32,432) (18,815)      
Net loss $ 59,949 $ (32,701) $ (19,312)      
Basic net income (loss) per share $ 0.44 $ (0.49) $ (0.31)      
Diluted net income (loss) per share $ 0.38 $ (0.49) $ (0.31)      
Consolidated Statements of Comprehensive Loss:            
Net loss $ 59,949 $ (32,701) $ (19,312)      
Comprehensive loss     (17,598)      
Consolidated Statements of Changes in Stockholders' Equity (Deficit):            
Contingent Earnout Liability Upon Closing Of The Merger     78,395      
Additional paid-in capital 418,575 393,872 418,575      
Accumulated deficit (230,458) (290,407) (230,458)      
Total stockholders' equity (deficit) 188,864 103,289 188,864      
Net Income (Loss) Attributable to Parent 59,949 (32,701) (19,312)      
Ending balance 188,864 103,289 188,864      
Consolidated Statements of Cash Flows:            
Net loss 59,949 (32,701) (19,312)      
Change in fair value of contingent earnout liability (65,761) (1,265) (67,026)      
Net Cash used in operating activities     (57,986)      
Noncash Investing and Financing Items [Abstract]            
Contingent earnout liability recognized upon the closing of the reverse recapitalization     78,395      
Adjustments            
Consolidated Balance Sheet:            
Contingent earnout liability (1,343) 3,286 (1,343)      
Total liabilities (1,343) 3,286 (1,343)      
Additional paid-in capital 20,121 20,121 20,121   $ 20,121  
Accumulated deficit (18,778) (23,407) (18,778)      
Total stockholders' equity (deficit) 1,343 (3,286) 1,343      
Total liabilities and stockholders’ equity (deficit)        
Consolidated Statements of Operations:            
Change in fair value of contingent earnout liability     (18,778)      
Total other income (expense), net 4,629 (23,407) (18,778)      
Loss before income taxes 4,629 (23,407) (18,778)      
Net loss $ 4,629 $ (23,407) $ (18,778)      
Basic net income (loss) per share $ 0.04 $ (0.34) $ (0.30)      
Diluted net income (loss) per share $ 0.03 $ (0.34) $ (0.30)      
Consolidated Statements of Comprehensive Loss:            
Net loss $ 4,629 $ (23,407) $ (18,778)      
Comprehensive loss     (18,778)      
Consolidated Statements of Changes in Stockholders' Equity (Deficit):            
Contingent Earnout Liability Upon Closing Of The Merger     (20,121)      
Additional paid-in capital 20,121 20,121 20,121   20,121  
Accumulated deficit (18,778) (23,407) (18,778)      
Total stockholders' equity (deficit) 1,343 (3,286) 1,343      
Net Income (Loss) Attributable to Parent 4,629 (23,407) (18,778)      
Ending balance 1,343 (3,286) 1,343      
Consolidated Statements of Cash Flows:            
Net loss 4,629 (23,407) (18,778)      
Change in fair value of contingent earnout liability (4,629) 23,407 (18,778)      
Net Cash used in operating activities          
Noncash Investing and Financing Items [Abstract]            
Contingent earnout liability recognized upon the closing of the reverse recapitalization     (20,121)      
As Restated            
Consolidated Balance Sheet:            
Contingent earnout liability 10,026 80,417 10,026      
Total liabilities 99,987 203,560 99,987      
Additional paid-in capital 438,696 413,993 438,696   438,696  
Accumulated deficit (249,236) (313,814) (249,236)      
Total stockholders' equity (deficit) 190,207 100,003 190,207      
Total liabilities and stockholders’ equity (deficit) 290,194   290,194      
Consolidated Statements of Operations:            
Change in fair value of contingent earnout liability     48,248      
Total other income (expense), net 88,140 (38,467) 30,233      
Loss before income taxes 64,106 (55,839) (37,593)      
Net loss $ 64,578 $ (56,108) $ (38,090)      
Basic net income (loss) per share $ 0.48 $ (0.83) $ (0.61)      
Diluted net income (loss) per share $ 0.41 $ (0.83) $ (0.61)      
Consolidated Statements of Comprehensive Loss:            
Net loss $ 64,578 $ (56,108) $ (38,090)      
Comprehensive loss     (36,376)      
Consolidated Statements of Changes in Stockholders' Equity (Deficit):            
Contingent Earnout Liability Upon Closing Of The Merger     58,274      
Additional paid-in capital 438,696 413,993 438,696   $ 438,696  
Accumulated deficit (249,236) (313,814) (249,236)      
Total stockholders' equity (deficit) 190,207 100,003 190,207      
Net Income (Loss) Attributable to Parent 64,578 (56,108) (38,090)      
Ending balance 190,207 100,003 190,207      
Consolidated Statements of Cash Flows:            
Net loss 64,578 (56,108) (38,090)      
Change in fair value of contingent earnout liability $ (70,390) $ 22,142 (48,248)      
Net Cash used in operating activities     (57,986)      
Noncash Investing and Financing Items [Abstract]            
Contingent earnout liability recognized upon the closing of the reverse recapitalization     $ 58,274